A professor of physiological nursing explains the differences between genetic predisposition and lifestyle factors for type 2 ...

The UCSF community is saddened at the passing of former UCSF faculty member William Rutter, PhD, whose collaborative and ...

The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary ...

Visual auras, like those that occur in migraines, may be signs of small injuries to the brain’s visual cortex, according to a clinical trial at UC San Francisco that tracked the appearance of these ...

A popular herbal supplement used by prostate cancer patients has been found to significantly reduce prostate specific antigen (PSA) levels—a protein in the blood that often indicates prostate ...

UC San FranciscoAI in Cancer Care, Targeted Therapies Among Cancer Conference Talks Research ...

UC San FranciscoNew and Easier Way to Monitor Inflammatory Bowel Disease in Kids Research ...

Bariatric surgeon Jonathan Carter discusses the pros and cons of surgery compared with GLP-1 drugs. For those with severe ...

This is part of our UCSF People series, highlighting employees from across UCSF with diverse roles and backgrounds through a ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Oral health has long been siloed from the rest of a person's health. But increasingly, researchers and clinicians, including those at UCSF, are finding ties between a person's oral health and their ...

Scientists at UCSF and Contineum Therapeutics have developed a drug that spurs the body to replace the protective insulation around nerve cells, myelin, that is lost in multiple sclerosis. If it works ...